Stuttering
32
8
8
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.1%
1 terminated out of 32 trials
92.9%
+6.3% vs benchmark
3%
1 trials in Phase 3/4
8%
1 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 13 completed trials
Clinical Trials (32)
Effectiveness of Virtually Simulated Intervention for Patients Having Stuttering
Development and Pilot Testing of Virtually Simulated Intervention for Patients Having Stuttering
Large Language Models for Stuttering Assessment and Therapy
Noninvasive Thalamocortical Neuromodulation With Low-Intensity Focused Ultrasound for Persistent Developmental Stuttering
Stuttering and Neuromodulation
Desensitization-Based Structured Intervention Program for Individuals With Stuttering
Speech Processing in Stuttering
Organization and Development of Motor Cortical Circuits for Speech Production in Stuttering
The Development of Stuttering in Young Children
Using Non-invasive Brain Stimulation to Explore Potential Treatments to Reduce Speech Errors in Adults Who Stutter
Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter
Network Connectivity and Temporal Processing in Adolescents Who Stutter
Genetic Linkage Studies of Stuttering
Shaping Motor Neural Functioning of Developmental Stuttering to Improve Fluency
Exploring the Nature, Assessment and Treatment of Stuttering
Computerized Based Analysis for Detection and Severity Assessment of Stuttering
Assessment of Stuttering Severity in Adults and Adolescences in Conversational and Narrative Contexts
How Stuttering and Gestures Influence the Intelligibility of Individuals With Down Syndrome
IBSR Intervention for Adults Who Stutter
Providing Speech Therapy Awareness in Private Schools